A direct effect of the IL28B polymorphism on the risk of HCC may not be inferred from these results, as SVR clearly improves the natural course of chronic HCV infection [47], [48] and, among non-responders, the effect of the IL28B polymorphism was indirect and associated with slightly lower levels of ALT and alpha-feto protein. This evidence concerns the gene GPT and hepatocellular carcinoma.